Number of Firm Shares. The Representatives may cancel the option at any time prior to its expiration by giving written notice of such cancellation to the Company.
Number of Firm Shares. Underwriter to be Purchased(1) Xxxxx Xxxxxxx & Co. 1,925,000 Wedbush Xxxxxx Securities Inc. 330,000 BMO Capital Markets Corp. 247,500 Xxxx Capital Partners LLC 247,500 Total: 2,750,000 (1) The Underwriters may purchase up to an additional 412,500 Option Shares, to the extent the option described in Section 3(b) of the Purchase Agreement is exercised, in the proportions and in the manner described in the Purchase Agreement. SCHEDULE II Issuer General Free Writing Prospectuses None. SCHEDULE III Pricing Information Number of Firm Shares to be Issued: 2,750,000 Offering Price: $17.25 per share Underwriting Discounts and Commissions: 6.25% SCHEDULE IV Executive Officers and Directors Subject to Lockup Xxxx Xxxxxxx Xxxxxx X. Xxxxxx C. Xxxx Xxxxxxxxxx Xxxxx Xxxx, M.D. Xxxxxx X. Xxxx Xxxxx X. Xxxxxx Xxxxxx X. Xxxxxx Xxxxxx X. Xxxxx Xxxxx Xxxxxxx Xxxxxxx Xxxxxxx EXHIBIT A Form of Lockup Agreement October ___, 2009 XXXXX XXXXXXX & CO. As Representative of the Several Underwriters c/o Xxxxx Xxxxxxx & Co. U.S. Bancorp Center 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Re: Proposed Public Offering of Clinical Data, Inc. Ladies and Gentlemen: The undersigned understands that Xxxxx Xxxxxxx & Co. (“Xxxxx Xxxxxxx”) will act as representative for a group of underwriters (the “Underwriters”) that proposes to enter into a Purchase Agreement (the “Purchase Agreement”) with Clinical Data, Inc. (the “Company”), providing for the public offering (the “Offering”) by the Underwriters of common stock of the Company (the “Common Stock”) pursuant to the Company’s registration statement on Form S-3 (File No. 333-143883). In consideration of the Underwriters’ agreement to purchase and make the Offering, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the undersigned hereby agrees that without the prior written consent of Xxxxx Xxxxxxx, on behalf of the Underwriters (which consent may be withheld in Xxxxx Xxxxxxx’x sole discretion), the undersigned will not, during the period commencing on the date hereof and ending 90 days after the date of the Purchase Agreement (the “Lock-Up Period”), directly or indirectly: (1) offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of any shares of the Common Stock, or any securities convertible into or exercisable or exchangeable for th...
Number of Firm Shares. Underwriter to be Purchased Xxxx Capital Partners, LLC 2,183,303 Total: 2,183,303 SCHEDULE II SELLING SHAREHOLDERS Selling Shareholders Total Number of Firm Shares to be Sold Total Number of Option Shares to be Sold DBSI Investments Ltd. 1,612,666 241,899 Xxxxxxx X. Xxxxx 570,637 85,595 Total: 2,183,303 327,494 SCHEDULE III Issuer General Use Free Writing Prospectuses: None. Permitted Free Writing Prospectuses: None. Additional Documents Incorporated by Reference: None. Other Information Included in the General Disclosure Package (Pricing Information):
Number of Firm Shares. Underwriter To Be Purchased Mxxxxxx Lynch, Pierce, Fxxxxx & Sxxxx Incorporated Mxxxxx Sxxxxxx & Co. Incorporated Banc of America Securities LLC Credit Suisse First Boston LLC Axxxx Hxxxxxxx, Inc. Citigroup Global Markets Inc. Jxxxxxxxx & Company AX Xxxxxxx & Sons Avondale Partners, LLC Total: 10,000,000 SCHEDULE III Pricing Terms SCHEDULE IV Subsidiaries of Herbalife Ltd. Jurisdiction of Subsidiary Type of Entity % Ownership Incorporation WH Capital Corporation Corporation 100% (indirect) Nevada WH Intermediate Holdings Ltd. Corporation 100 % Cayman Islands WH Luxembourg Holdings S.à RL Corporation 100% (indirect) Luxembourg WH Luxembourg Intermediate Holdings S.à RL Corporation-Luxembourg LLC —Delaware 100% (indirect) Luxembourg and Delaware Herbalife Luxembourg Distribution S.à RL Corporation 100% (indirect) Luxembourg Herbalife International Luxembourg S.à RL Corporation 100% (indirect) Luxembourg HLF Luxembourg Holdings S.à RL Corporation 100% (indirect) Luxembourg HBL Ltd. Corporation 100% (indirect) Cayman Islands Herbalife Distribution Ltd. Corporation 100% (indirect) Cayman Islands Herbalife International, Inc. Corporation 100% (indirect) Nevada Herbalife International Argentina S.A. Corporation 100% (indirect) Argentina Herbalife Australasia Pty, Ltd. Corporation 100% (indirect) Australia Herbalife Foreign Sales Corporation Corporation 100% (indirect) Barbados Herbalife International Belgium, S.A. Corporation 100% (indirect) Belgium Herbalife International Do Brasil Ltda. Limited Company — Brazil Corporation- Delaware 100% (indirect) Brazil and Delaware Herbalife of Canada, Ltd. Corporation 100% (indirect) Canada Importadora Y Distribuidora Herbalife International de Chile Limitada Limited Liability Partnership 100% (indirect) Chile Herbalife (China) Health Products Ltd. Corporation 100% (indirect) Republic of China Herbalife International Costa Rica, Sociedad De Responsabilidad Limitada Corporation 100% (indirect) Costa Rica Herbalife Denmark ApS Corporation 100% (indirect) Denmark Herbalife Dominicana, S.A. Corporation 100% (indirect) Dominican Republic Herbalife Del Ecuador, S.A. Corporation 100% (indirect) Ecuador Herbalife International Finland OY Corporation 100% (indirect) Finland Herbalife International France, S.A. Corporation 99.99% (indirect) ..01 (held by nominee) France Herbalife International Deutschland GmbH Corporation 100% (indirect) Germany Herbalife International Greece S.A. Corporation 100% (indirect) Greece Herbalife Internati...
Number of Firm Shares. Maximum Number of Optional Shares: --------------- [Initial Offering Price to Public: $ per Share] ------------- Purchase Price by Designated Underwriter: $ per Share ------------- Form of Designated Shares: Definitive form, to be made available for checking at least twenty-four hours prior to the Time of Delivery at the office of The Depository Trust Company or its designated custodian Specified Funds for Payment of Purchase Price: Federal (same day) funds
Number of Firm Shares. Underwriters To Be Purchased Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 1,487,500 Xxxxxx Xxxxxxx & Co. LLC 1,487,500 X.X. Xxxxxx Securities LLC 262,500 Xxxxxx, Xxxxxxxx & Company, Incorporated 262,500 Total: 3,500,000 SCHEDULE II GRAMERCY PROPERTY TRUST INC. Documents Comprising the Time of Sale Prospectus
Number of Firm Shares. Underwriters to be Purchased Xxxxxx, Xxxxxxxx & Company, Incorporated 3,640,000 Xxxxxxx Xxxxx & Company, L.L.C. 2,100,000 Signal Hill Capital Group LLC 1,260,000 Total: 7,000,000 SCHEDULE II Selling Shareholders Number of Number of Option Firm Shares Shares to Selling Shareholder to be Sold be Sold H&E Buckingham Limited Partnership 2,707,950 0 Xxxxxx X. Xxxxxxxxxx Living Trust 792,050 0 Total 3,500,000 0 SCHEDULE III Lock-ups Agreements Executed by Directors and Officers Xxxxxx X. Xxxxxxxxxx Xx. Xxxxx X. Gallentine Xx. Xxxxxxx Xxxxx Crane Dr. R. Xxxx Xxxxxxxx Xx. Xxxxxx X. Saban Xxxxx X. Xxxxxxx H. Xxxxxx Xxxxxx Xx. Xxxxxx X. Shape Xx. Xxxxxx X. Kerr Xxxxxxx X. Xxxxx Xxxxxxxxx X. Xxxxxxx Xxxx X. Xxxxxx Xx. Xxxxxx X. Paxton Xxxxx X. Xxxxxxxx Xxxxxxx Xxxxxxxxxx
Number of Firm Shares. (1) Xxxxx Xxxxxxx & Co. XX Xxxxx Securities Corporation RBC Xxxx Xxxxxxxx Inc.
Number of Firm Shares. Underwriters To Be Purchased ------------------------------------------ --------------------------------- Cruttenden Roth Xxxorporated.............. TOTAL.........................
Number of Firm Shares. Any such election to purchase Optional Shares may be exercised only by written notice from you to the Company, given within a period of 30 calendar days after the date of this Agreement, setting forth the aggregate number of Optional Shares to be purchased and the date on which such Optional Shares are to be delivered, as determined by you but in no event earlier than the First Time of Delivery (as defined in Section 4 hereof) or, unless you and the Company otherwise agree in writing, earlier than two or later than ten business days after the date of such notice.
